Version-1 (July-August 2017)
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Meiotic Studies in Papaya (Carica papaya (L)) infected by Papaya Ring Spot Virus (PRSV) |
| Country | : | India |
| Authors | : | Ravindra Kumar Pandey |
| : | 10.9790/264X-03040104 ![]() |
Abstract: Papaya (Carica papaya L.) is a tropical and subtropical crop widely cultivated for edible fruits. It is member of the small family Caricaceae .Papaya is one of the few rapidly growing and heavily yielding fruit trees. In the peninsular region it bears fruits throughout the year, while under north Indian conditions it is in fruiting for about four month beginning from January. Papaya trees are affected by some fungi from seedling to fruit, that reduces the viability of plant and fruit numbers and quality. Except fungal diseases viral diseases also affect from foliar to fruiting stages (Leaf curl and ring spot diseases). Trees affected do not die immediately but their fruit bearing capacity is diminished. Plants infected by PRSV develop a range of symptoms including ringed spots on the fruit, for which the virus is named. Other symptoms in include mosaic coloration and chlorosis of the leaves.
[1] Khurana, S.M.P. (1968). Studies on virus disease of papaya (carica papaya L.) in Gorakhpur. Ph. D. thesis, Uni. Of Gorakhpur, India.
[2] Muniyappa, V. (2003) Plant disease Scenario in south India. Indian phytopato, 56:328.
[3] Rawlins, T.E. and Tompkins, C.M.(1936). Studies on the effect of carborandum as abrasive in plant virus inoculation. Phytopathology, 26:578. 66.
[4] Alexander M. P., 1969 - Diferential staining of aborted and nonaborted pollen. Stain Technology, 44:117-122.
[5] Belling. 1926. Iron acetocarmine method of fixing and staining chromosomes. Biology Bulletin 58: 355-363.
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Neutrophils are major source of inflammatory and pro-inflammatory cytokines which play an important role in obesity related cardio-metabolic complications. Little is known about neutrophil activation markers in childhood obesity. Therefore, we investigated the hypothesis that, the component of the innate immune system is activated in childhood obesity through assessment of the expression of CD66b as a specific marker of neutrophil activation and plasma MPO which is a product of activated neutrophil............
[1] WHO (2014): Global school-based student health survey. Online database.Geneva:WHO, 2014. (Accessed 25 January 2014, at http://www. who.int/chp/gshs/en/.)
[2] de Onis M, Blossner M, Borghi E. Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010; 92: 1257–64.
[3] Gregor M. F. and Hotamisligil G. S. "Inflammatory mechanisms in obesity," Annual Review of Immunology. 2011; 29: 415–445.
[4] Hotamisligil G. S. "Inflammation and metabolic disorders," Nature. 2006; 444 (7121): 860–867.
[5] Yushimora A, Ohnishi S, Orito C, Kawahara Y, Takasaki H, Takeda H, Sakamoto N,Hashino S. Association of Peripheral Total and Differential Leukocyte Counts with Obesity-Related Complications in Young Adults. Obes Facts 2015; 8:1–16..
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Tuberculosis (TB) continues to be a major worldwide health problem and is the leading killer of youth and adults in developing countries, being responsible for more deaths than any other single infectious organism [1]. 5–15% of the people infected with M. tuberculosis (estimated 2–3 billion) will develop TB disease during their lifetime [1]. Bacillus Calmette–Guerin (BCG), an attenuated strain of Mycobacterium bovis is the only vaccine currently available against TB. This is the world's most widely used vaccine and being directed against the world's leading cause of infectious disease mortality, BCG is the most controversial vaccine in current use [2]. The efficacy of BCG vaccine in the prevention of tuberculosis has shown considerable variation in different populations and trials [3].............
[1] World Health Organization. Global Tuberculosis Report 2016 (WHO Press, Switzerland, 2016)
[2] P.E.M. Fine and L.C. Rodrigues, Modern vaccines: Mycobacterial diseases, Lancet, 335 1990, 1016-1020.
[3] G.A. Colditz, T.F. Brewer, C.S Berkey , M.E. Wilson , E. Burdick , H.V. Fineberg and F. Mosteller, Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature, JAMA, 27, 1994, 698-702.
[4] A. Sakula, BCG: who were Calmette and Guerin?, Thorax, 38, 1983, 806-812.
[5] T. Oettinger, M. Jorgensen, A. Ladefoged, K. Haslov and P. Andersen, Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree, Tuberc Lung Dis, 79, 1999, 243-250.
